We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,631

Foreign Investors Active in the U.S. - Stricter Enforcement of Criminal Laws Against Senior Management and Ways to Stay Clean for Investors
  • Milbank Tweed Hadley & McCloy LLP
  • USA
  • April 20 2016

Company boards and management should take note of the U.S. Department of Justice’s increasing focus on the prosecution of individual executives and


The HSR Act’s “Investment” Exemption - Strategic Considerations in Light of Recent Enforcement
  • Locke Lord LLP
  • USA
  • April 22 2016

On April 4, 2016 the Department of Justice (DOJ) sued ValueAct Capital (ValueAct), an "activist" investment fund, for violation of the


Healthcare transactions: year in review - January 2016
  • Bass, Berry & Sims PLC
  • USA
  • January 8 2016

The explosive rate of healthcare mergers and acquisitions in 2015 reveals the importance of collaboration and integration across all sectors. Mergers


The FTC's Three Current Hospital Merger Challenges: Will the FTC Ever Lose?
  • Ober Kaler
  • USA
  • March 29 2016

Beginning with the Federal Trade Commission's 2007 decision in Evanston Northwestern Healthcare Corp., holding that a hospital merger in the North


DOJ Action Against ValueAct for HSR Act Violation Signals More Caution for Minority Investors and Activist Stockholders
  • Hogan Lovells
  • USA
  • April 15 2016

On April 4, 2016, the U.S. Department of Justice (DOJ) filed a complaint in federal court against activist investor ValueAct Capital (ValueAct) for


Antitrust, competition and economic regulation - Spring 2015
  • Hogan Lovells
  • European Union, USA
  • April 2 2015

The Consumer Rights Act 2015 (the “CRA15”) received Royal Assent on 26 March 2015. Section 82 and Schedule 8 of the CRA15 introduces a package of


Potential private equity pitfalls under Hart-Scott-Rodino
  • Winston & Strawn LLP
  • USA
  • September 13 2011

The Hart-Scott-Rodino Antitrust Improvements Act (“HSR” or the “Act”) requires the reporting of transactions, including acquisitions of voting securities or assets, that satisfy certain dollar thresholds


Physician Owned Labs Affiliating with Hospitals
  • Epstein Becker Green
  • USA
  • January 20 2016

Hospital-physician practice acquisitions represent a large segment of the very active healthcare mergers and acquisitions market, which will likely


Reconsidering NDAs in light of Martin Marietta Materials, Inc. v. Vulcan Materials Co.
  • Kramer Levin Naftalis & Frankel LLP
  • USA
  • May 21 2012

On May 4, 2012, the Delaware Court of Chancery held that Martin Marietta Materials had violated a pair of confidentiality agreements with Vulcan Materials and issued a 4-month temporary injunction suspending Martin Marietta’s hostile exchange offer for Vulcan and related proxy contest


DOJ Files Suit Against An “Activist Investor”
  • Sullivan & Cromwell LLP
  • USA
  • April 7 2016

On Monday, April 4, 2016, the U.S. Department of Justice (“DOJ”) filed a complaint against three ValueAct Capital-related entities (collectively